Sagittarius Life Science Corp. (3205) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sagittarius Life Science Corp. (3205:TWSE), powered by AI.

Current Price
$52.80
Sector
Healthcare
What is the Sagittarius Life Science Corp. stock price forecast?

Sagittarius Life Science Corp. is currently trading at $52.80. View real-time AI analysis on Alpha Lenz.

What is Sagittarius Life Science Corp. insider trading activity?

View the latest insider trading data for Sagittarius Life Science Corp. on Alpha Lenz.

What is Sagittarius Life Science Corp.'s P/E ratio?

View Sagittarius Life Science Corp.'s valuation metrics on Alpha Lenz.

Sagittarius Life Science Corp.

TWSE · 3205
NT$52.80+0.00(+0.00%)
Ask about Sagittarius Life Science Corp.'s future dividend policy...
Alpha Chat Insight

Sagittarius Life Science Corp.'s ROE is -6.8%. Explore profitability and growth together.

Ask for details

Company Overview

Sagittarius Life Science Corp. is a biotechnology and health-focused company specializing in the research, development, and production of both Chinese and Western medicines as well as a diverse array of health products. Founded in 1998 and headquartered in Taipei, the company’s core operations span nutritional supplements, organic and natural foods, probiotic fermentation products, and beauty care ingredients. Additionally, Sagittarius Life Science Corp. provides health-related daily necessities, pet food, and functional beverages, catering to varying consumer health and wellness needs across Taiwan, broader Asia, and select international markets. The company’s activities extend into the innovative development of plant-derived pharmaceuticals and traditional herbal medicines, reflecting a blend of modern biotechnological approaches with established medicinal practices. Through its integrated model that covers R&D, manufacturing, and technical consulting for pharmaceutical products, Sagittarius Life Science Corp. maintains a significant presence in the healthcare and specialty food sectors, with a focus on promoting well-being and supporting advancements in preventive and supplementary health care.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$346.08MRevenue
0.00Shares Out
0Employees

Margins

16.68%Gross
-11.40%EBITDA
-16.91%Operating
-14.41%Pre-Tax
-14.41%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-13.19%Rev 3Yr
-9.12%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-6.27%ROA
-6.83%ROE
-6.26%ROIC

Financial Health

NT$151.55MCash & Cash Equivalents
NT$-124.64MNet Debt
2.58%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sagittarius Life Science Corp. (ticker: 3205) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 52.8 with a P/E ratio of -x and P/B of -x.

ROE is -6.83% and operating margin is -16.91%. Annual revenue is $346M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sagittarius Life Science Corp. (3205) Stock Forecast 2026 $52.80 — Price, Financials & Analyst Targets | Alpha Lenz